Brain Health Devices Market Report 2025

This brain health devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The brain health devices market size has grown strongly in recent years. It will grow from $11.07 billion in 2024 to $11.9 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increase in prevalence of neurological disorders, growth in aging population, growth in the number of diagnostic centers and hospitals, growth in patient awareness about neurological diseases, and increase support from governments.

The brain health devices market size is expected to see strong growth in the next few years. It will grow to $15.73 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to improved reimbursement policies, increasing incidence of sleep disorders, increasing focus on personalized medicine, rising demand for non-invasive procedures, and rise in regulatory approvals for new devices. Major trends in the forecast period include technological advancements, integration of artificial intelligence, integration of mobile health apps, development of personalized brain health products, advancements in brain monitoring devices.

The growing prevalence of neurological disorders is anticipated to drive the expansion of the brain health devices market. Neurological disorders, which impact the nervous system including the brain, spinal cord, and nerves, lead to various cognitive, motor, and sensory impairments. This increase in prevalence is primarily due to an aging population and the rising incidence of chronic diseases such as diabetes and hypertension. Environmental and lifestyle factors, along with advancements in diagnostic techniques and genetic predispositions, also contribute to the increasing number of reported cases. Brain health devices are designed to monitor brain activity and deliver targeted therapies to manage symptoms, enhance cognitive function, and improve patient outcomes. For example, a report by the Alzheimer's Association, a U.S.-based nonprofit health organization, indicated that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia rose from 6.5 million in 2022 to 6.9 million in 2024. Thus, the increasing prevalence of neurological disorders is fueling the growth of the brain health devices market.

Leading companies in the brain health devices market are concentrating on modernizing non-invasive and comfortable monitoring solutions, such as brain monitoring systems, to enhance diagnostic accuracy, improve patient outcomes, and streamline the management of neurological conditions. These brain monitoring systems provide continuous, non-invasive tracking of brain activity, allowing for early detection and management of neurological disorders. For example, in November 2022, Neurosteer Inc., a U.S.-based medical equipment manufacturer, received FDA clearance for its single-channel electroencephalogram (EEG) brain monitoring platform. This clearance enables the versatile system to be used in various clinical settings. The platform supports continuous brain monitoring in intensive care units (ICUs) for critical interventions and aids in the early detection of pre-symptomatic cognitive decline, such as Alzheimer's, Parkinson's, and dementia, in physician offices.

In March 2024, Linus Health Inc., a U.S.-based software company, acquired Aural Analytics Inc. for an undisclosed sum. This acquisition enhances Linus Health's cognitive assessment platform by incorporating advanced speech analytics, which improves the accuracy of detecting cognitive impairments. The integration broadens the range of tools available to clinicians and researchers and extends Linus Health's presence in the life sciences sector. Aural Analytics Inc. is a U.S.-based healthcare company specializing in brain health analytics solutions.

Major companies operating in the brain health devices market are Johnson & Johnson Services Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, electroCore Inc., Masimo Corporation, Integra LifeSciences Corporation, LivaNova plc, Natus Medical Incorporated, Cadwell Industries Inc., NeuroSky Inc., Neuropace Inc., Compumedics Limited, Magstim Co. Ltd., Mindmaze SA, Brain Products GmbH, Emotiv Inc., Electrical Geodesics Inc., BrainScope Company Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Bio-Signal Group Corp., Cognionics Inc.

North America was the largest region in the brain health devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain health devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Brain health devices are tools designed to monitor, assess, or enhance cognitive functions, brain activity, and mental well-being. These devices include wearable headsets that track brainwave patterns and neurostimulation tools that help manage conditions such as depression or epilepsy. Their goals are to promote overall brain health, facilitate the early detection of neurological disorders, and support cognitive enhancement through methods such as brain training and biofeedback.

The primary types of devices in the brain health market include magnetic resonance imaging (MRI), magnetoencephalography (MEG), computed tomography (CT), transcranial Doppler devices, and others. MRI is a non-invasive technique that employs magnetic fields and radio waves to produce detailed images of the brain's structure. Procedures range from invasive to non-invasive, with applications including sleep disorders, accidental injuries, Alzheimer's disease, epilepsy, stroke, and more. The various end-users of these devices include hospitals and clinics, diagnostic imaging centers, homecare settings, assisted living facilities, and other healthcare environments.

The brain health devices market research report is one of a series of new reports that provides brain health devices market statistics, including brain health devices industry global market size, regional shares, competitors with a brain health devices market share, detailed brain health devices market segments, market trends, and opportunities, and any further data you may need to thrive in the brain health devices industry. This brain health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The brain health devices market consists of sales of electroencephalography (EEG) headsets, neurostimulation devices, brain training software, cognitive assessment tools, and wearable biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.